A hybrid approach to re-engineer a SARS-CoV-1 neutralizing antibody against SARS-CoV-2

FHS
August 21, 2023
11:47 am

A hybrid approach involving a combination of conventional discovery and antibody repurposing to combat COVID-19.

Ipsen returns to Marengo Therapeutics for new trispecific deal

Ipsen and Marengo Therapeutics are expanding a deal to include two trispecific antibody assets that tackle so-called cold tumors, which do not typically respond well

June 8, 2024

The diverse immunological functions of megakaryocytes

Megakaryocytes (MKs), known for their role in platelet production, have emerged as critical players in immune responses, showcasing versatility in both physiological and pathological contexts.

January 17, 2025

Common Bacterial Infection Might Be Key to Lung Transplant Rejection

Lung transplant recipients are highly susceptible to infection, and Pseudomonas aeruginosa is a leading cause of bacterial pneumonia for them. After lung transplantation, infection with

February 6, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.